Literature DB >> 11306517

Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.

J B Demoulin1, J Van Snick, J C Renauld.   

Abstract

Murine interleukin (IL)-9 inhibits apoptosis in murine T lymphomas via signal transducer and activator of transcription (STAT) factors. After transfection of the human IL-9 receptor, human IL-9 had a similar antiapoptotic activity, but, unlike the mouse protein, inhibited proliferation. This effect was correlated with the level of receptor expression and the extent of STAT phosphorylation. Expression of a moderate level of suppressor of cytokine signaling 3 (SOCS3) reduced STAT activation by human IL-9 and prevented inhibition of growth but not of apoptosis. Using mutated IL-9 receptors, we showed that inhibition of proliferation was correlated with STAT1 and STAT3 activation by IL-9 and induction of the cell cycle inhibitor p19/ink4d, a STAT3 target gene. Activation of STAT1 by IFN-gamma did not result in cell growth arrest. In this model, cell growth inhibition is therefore associated with a higher number of receptors, a more robust STAT activation, and a greater sensitivity to SOCS3 expression, compared to apoptosis inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306517

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  9 in total

Review 1.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

2.  IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.

Authors:  Hongmei Li; Bardia Nourbakhsh; Melissa Cullimore; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

Review 3.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

Review 4.  IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.

Authors:  Hongmei Li; Abdolmohamad Rostami
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

Review 5.  IL-9-producing T cells: potential players in allergy and cancer.

Authors:  Pornpimon Angkasekwinai; Chen Dong
Journal:  Nat Rev Immunol       Date:  2020-08-12       Impact factor: 53.106

6.  Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children's Oncology Group report.

Authors:  Xin Long; Robert B Gerbing; Todd A Alonzo; Michele S Redell
Journal:  Oncotarget       Date:  2017-09-28

Review 7.  The Roles of IRF-8 in Regulating IL-9-Mediated Immunologic Mechanisms in the Development of DLBCL: A State-of-the-Art Literature Review.

Authors:  Mingyue Cai; Na Chen
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

8.  Evolution of Class I cytokine receptors.

Authors:  Clifford Liongue; Alister C Ward
Journal:  BMC Evol Biol       Date:  2007-07-18       Impact factor: 3.260

9.  Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.

Authors:  Jing Zhang; Wei-da Wang; Qi-Rong Geng; Liang Wang; Xiao-Qin Chen; Cheng-Cheng Liu; Yue Lv
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.